Everyone please send in letters to the people listed below explaining how much you need this medication and urge for the public advisory committee meeting to be scheduled. This is the meeting where we get to plead our case. Mention that the FDA claimed in their press release that they would have this meeting to discuss a "limited return" of the drug. The more letters the better so also have your family and friends send in letters as well if you are so inclined. Also I am urging everyone to contact their congressional representives and let them know what the FDA is doing to their constituents. Political pressure is the best kind of pressure.

Dr. Stephen K Galson, M.D., M.P.H.Director, Center for Drug Evaluation and ResearchU.S. Food and Drug Administration5600 Fishers Lane , Rockville MD 20857-0001

and/orDouglas Throckmorton, M.D.Deputy Director, Center for Drug Evaluation and ResearchU.S. Food and Drug Administration5600 Fishers Lane , Rockville MD 20857-0001